HB1024: In preliminary provisions, further providing for definitions; in program, further providing for lawful use of medical marijuana; in practitioners, further providing for duration; in patients, further providing for caregivers; in medical marijuana organizations, further providing for permits, for relocation and for convictions prohibited; in medical marijuana controls, further providing for electronic tracking, for grower/processors, for storage and transportation and for laboratory; in dispensaries, further providing for dispensing to patients and caregivers and for facility requirements; in tax on medical marijuana, further providing for Medical Marijuana Program Fund; in administration, further providing for temporary regulations; in Medical Marijuana Advisory Board, further providing for advisory board and for regulations based on recommendations of advisory board; in offenses related to medical marijuana, further providing for disclosure of information prohibited; in academic clinical research centers and clinical registrants, further providing for academic clinical research centers and for clinical registrants; and, in miscellaneous provisions, further providing for applicability.
Legislative Summary
An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions; in program, further providing for lawful use of medical marijuana; in practitioners, further providing for duration; in patients, further providing for caregivers; in medical marijuana organizations, further providing for permits, for relocation and for convictions prohibited; in medical marijuana controls, further providing for electronic tracking, for grower/processors, for storage and transportation and for laboratory; in dispensaries, further providing for dispensing to patients and caregivers and for facility requirements; in tax on medical marijuana, further providing for Medical Marijuana Program Fund; in administration, further providing for temporary regulations; in Medical Marijuana Advisory Board, further providing for advisory board and for regulations based on recommendations of advisory board; in offenses related to medical marijuana, further providing for disclosure of information prohibited; in academic clinical research centers and clinical registrants, further providing for academic clinical research centers and for clinical registrants; and, in miscellaneous provisions, further providing for applicability.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
